These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 7791879
1. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nowak MA, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, McAdam S, Klenerman P, Köppe B, Sigmund K, Bangham CR. Nature; 1995 Jun 15; 375(6532):606-11. PubMed ID: 7791879 [Abstract] [Full Text] [Related]
2. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual. Harrer T, Harrer E, Barbosa P, Kaufmann F, Wagner R, Brüggemann S, Kalden JR, Feinberg M, Johnson RP, Buchbinder S, Walker BD. J Immunol; 1998 Nov 01; 161(9):4875-81. PubMed ID: 9794421 [Abstract] [Full Text] [Related]
3. Immune responses against multiple epitopes. Nowak MA, May RM, Sigmund K. J Theor Biol; 1995 Aug 07; 175(3):325-53. PubMed ID: 7475080 [Abstract] [Full Text] [Related]
4. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals. Thorn M, Tang S, Therrien D, Kløverpris H, Vinner L, Kronborg G, Gerstoft J, Corbet S, Fomsgaard A. APMIS; 2007 Jun 07; 115(6):757-68. PubMed ID: 17550385 [Abstract] [Full Text] [Related]
5. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef. Thakar MR, Bhonge LS, Lakhashe SK, Shankarkumar U, Sane SS, Kulkarni SS, Mahajan BA, Paranjape RS. J Infect Dis; 2005 Sep 01; 192(5):749-59. PubMed ID: 16088824 [Abstract] [Full Text] [Related]
7. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD. J Immunol; 1996 Apr 01; 156(7):2616-23. PubMed ID: 8786327 [Abstract] [Full Text] [Related]
11. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes. van Baalen CA, Guillon C, van Baalen M, Verschuren EJ, Boers PH, Osterhaus AD, Gruters RA. Eur J Immunol; 2002 Sep 01; 32(9):2644-52. PubMed ID: 12207349 [Abstract] [Full Text] [Related]
14. Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. Rowland-Jones SL, Phillips RE, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JG, Rothbard JA, Bangham CR, Rizza CR. AIDS Res Hum Retroviruses; 1992 Aug 01; 8(8):1353-4. PubMed ID: 1466955 [No Abstract] [Full Text] [Related]
15. Escape of human immunodeficiency virus from immune control. McMichael AJ, Phillips RE. Annu Rev Immunol; 1997 Aug 01; 15():271-96. PubMed ID: 9143689 [Abstract] [Full Text] [Related]
16. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication. Wagner R, Leschonsky B, Harrer E, Paulus C, Weber C, Walker BD, Buchbinder S, Wolf H, Kalden JR, Harrer T. J Immunol; 1999 Mar 15; 162(6):3727-34. PubMed ID: 10092836 [Abstract] [Full Text] [Related]